ArticleWorld journal of surgical oncology2021

Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types.

Tamami Morisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.